Re:Human body-on-chip platform could speed up drug testing
by kovek on Wednesday April 29, 2020 @09:09PM
(#23026454)
Is it possible that these proxies you mention could weed out compounds incorrectly? For example, if we have a liver proxy that fails on drug A, is it possible that drug A will work fine in the human body provided that there’s a lot of other processes that could contribute to the liver?
Re:Human body-on-chip platform could speed up drug testing
by refurb on Wednesday April 29, 2020 @09:36PM
(#23026600)
Absolutely. That's the flip side of in vitro and animal testing. You might see a negative signal and stop development, only to find out that it can't be replicated in humans.
The cell line assays replicate much of what happens in humans, but not all of it, in particular the interactions between different tissues. For example, a drug might be toxic in a liver assay because a reactive metabolite damages the cells. But in an actual human, you might never see those high of concentrations in the liver or there may be a process (like glutathione adducts) that deactivates the metabolite and prevents cell damage.
Re:Human body-on-chip platform could speed up drug testing
by hprotagonist on Thursday April 30, 2020 @09:32AM
(#23030583)
right. i want to go beyond cell assays, i want high throughput organ slices that preserve important morphologies.
it’s not a perfect model, but i think it’s a better proxy than a mouse.
Those assays are super helpful, but don't replicate what happens in humans. They are good boxes to check, and can help weed out compounds early, but just because a compound passes the assay doesn't guarantee something weird won't pop up in humans.